These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8322703)

  • 1. Failure of the International Normalized Ratio to generate consistent results within a local medical community.
    Ng VL; Levin J; Corash L; Gottfried EL
    Am J Clin Pathol; 1993 Jun; 99(6):689-94. PubMed ID: 8322703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the inter-laboratory harmonization of the international normalized ratio (INR): utilizing the concept of transference to estimate and/or validate international sensitivity index (ISI) and mean normal prothrombin time (MNPT) values and/or to eliminate measurement bias.
    Favaloro EJ; McVicker W; Zhang Y; Hamdam S; Huynh M; Peris P; O'Neal M; Hocker N
    Clin Lab Sci; 2012; 25(1):13-25. PubMed ID: 22458045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harmonizing the International Normalized Ratio (INR) : Standardization of Methods and Use of Novel Strategies to Reduce Interlaboratory Variation and Bias.
    Favaloro EJ; McVicker W; Lay M; Ahuja M; Zhang Y; Hamdam S; Hocker N
    Am J Clin Pathol; 2016 Feb; 145(2):191-202. PubMed ID: 26800763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant therapy monitoring with international normalized ratio at US academic health centers.
    Yim JM; Albers GW; Vlasses PH
    Ann Pharmacother; 1996 Dec; 30(12):1390-5. PubMed ID: 8968449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive thromboplastins do not improve INR precision.
    Ng VL; Valdes-Camin R; Gottfried EL; Echaves SA; Stead AG; Ebert RF
    Am J Clin Pathol; 1998 Mar; 109(3):338-46. PubMed ID: 9495209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASHP therapeutic position statement on the use of the International Normalized Ratio system to monitor oral anticoagulant therapy.
    Am J Health Syst Pharm; 1995 Mar; 52(5):529-31. PubMed ID: 7606561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents.
    Horsti J; Uppa H; Vilpo JA
    Clin Chem; 2005 Mar; 51(3):553-60. PubMed ID: 15665046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents.
    Kazama M; Suzuki S; Abe T; Tahara C; Shimazu C; Akiyama Y; Higashi K; Ishiguro I; Kimura T; Motoi S
    Thromb Haemost; 1990 Dec; 64(4):535-41. PubMed ID: 2084938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of the international normalized ratio for monitoring the induction phase of warfarin: comparison with the prothrombin time ratio.
    Johnston M; Harrison L; Moffat K; Willan A; Hirsh J
    J Lab Clin Med; 1996 Aug; 128(2):214-7. PubMed ID: 8765218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard.
    Kaatz SS; White RH; Hill J; Mascha E; Humphries JE; Becker DM
    Arch Intern Med; 1995 Sep; 155(17):1861-7. PubMed ID: 7677552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC/ISTH working group on prothrombin time/international normalized ratio standardization.
    van den Besselaar AMHP; Stavelin A; Kitchen S; Bryant M; Tripodi A; Scalambrino E; Clerici M; Herbel P; Jünschke A; Meyer Dos Santos S; Meijer P; Niessen RWLM; Meijers JCM; Thelwell C; Cuker A; Kung C; Cao Z; Zander N; Iwasaki Y; Depasse F; van Rijn C; Baktawar S; Abdoel C; Cobbaert CM
    J Thromb Haemost; 2024 Apr; 22(4):1236-1248. PubMed ID: 38128762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically significant differences in the International Normalized Ratio measured with reagents of different sensitivities. SPAF Investigators. Stroke Prevention in Atrial Fibrillation.
    Lind SE; Pearce LA; Feinberg WM; Bovill EG
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):215-27. PubMed ID: 10456611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-Canada survey of prothrombin time testing: Does the establishment of local ISI values improve the accuracy of international normalized ratio reporting? Thrombosis Interest Group of Canada.
    Johnston M; Brigden M
    Am J Clin Pathol; 1998 Nov; 110(5):683-90. PubMed ID: 9802355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use and limitations of the INR system.
    Ts'ao C; Neofotistos D
    Am J Hematol; 1994 Sep; 47(1):21-6. PubMed ID: 8042611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Xa and anti-IIa drugs alter international normalized ratio measurements: potential problems in the monitoring of oral anticoagulants.
    Tobu M; Iqbal O; Hoppensteadt D; Neville B; Messmore HL; Fareed J
    Clin Appl Thromb Hemost; 2004 Oct; 10(4):301-9. PubMed ID: 15497016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.